Hansa Biopharma (Sweden) Market Value
| HNSA Stock | SEK 25.14 1.66 7.07% |
| Symbol | Hansa |
Hansa Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hansa Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hansa Biopharma.
| 01/28/2025 |
| 02/27/2025 |
If you would invest 0.00 in Hansa Biopharma on January 28, 2025 and sell it all today you would earn a total of 0.00 from holding Hansa Biopharma AB or generate 0.0% return on investment in Hansa Biopharma over 30 days. Hansa Biopharma is related to or competes with Oncopeptides, ExpreS2ion Biotech, BioInvent International, and Zealand Pharma. Hansa Biopharma AB , a biopharmaceutical company, focuses on developing novel immunomodulatory enzymes for organ transpl... More
Hansa Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hansa Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hansa Biopharma AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 36.81 | |||
| Value At Risk | (4.80) | |||
| Potential Upside | 7.07 |
Hansa Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hansa Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hansa Biopharma's standard deviation. In reality, there are many statistical measures that can use Hansa Biopharma historical prices to predict the future Hansa Biopharma's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.13) | |||
| Treynor Ratio | (0.18) |
Hansa Biopharma AB Backtested Returns
Hansa Biopharma AB holds Efficiency (Sharpe) Ratio of -0.0684, which attests that the entity had a -0.0684 % return per unit of risk over the last 3 months. Hansa Biopharma AB exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Hansa Biopharma's Standard Deviation of 4.58, risk adjusted performance of (0.02), and Market Risk Adjusted Performance of (0.17) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.93, which attests to possible diversification benefits within a given portfolio. Hansa Biopharma returns are very sensitive to returns on the market. As the market goes up or down, Hansa Biopharma is expected to follow. At this point, Hansa Biopharma AB has a negative expected return of -0.33%. Please make sure to check out Hansa Biopharma's total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if Hansa Biopharma AB performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.41 |
Modest reverse predictability
Hansa Biopharma AB has modest reverse predictability. Overlapping area represents the amount of predictability between Hansa Biopharma time series from 28th of January 2025 to 12th of February 2025 and 12th of February 2025 to 27th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hansa Biopharma AB price movement. The serial correlation of -0.41 indicates that just about 41.0% of current Hansa Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.41 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.4 |
Hansa Biopharma AB lagged returns against current returns
Autocorrelation, which is Hansa Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Hansa Biopharma's stock expected returns. We can calculate the autocorrelation of Hansa Biopharma returns to help us make a trade decision. For example, suppose you find that Hansa Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Hansa Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Hansa Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Hansa Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Hansa Biopharma stock over time.
Current vs Lagged Prices |
| Timeline |
Hansa Biopharma Lagged Returns
When evaluating Hansa Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Hansa Biopharma stock have on its future price. Hansa Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Hansa Biopharma autocorrelation shows the relationship between Hansa Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in Hansa Biopharma AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hansa Stock Analysis
When running Hansa Biopharma's price analysis, check to measure Hansa Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hansa Biopharma is operating at the current time. Most of Hansa Biopharma's value examination focuses on studying past and present price action to predict the probability of Hansa Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hansa Biopharma's price. Additionally, you may evaluate how the addition of Hansa Biopharma to your portfolios can decrease your overall portfolio volatility.